Mutations

MAPT G55R

Overview

Pathogenicity: Frontotemporal Dementia : Pathogenic
Clinical Phenotype: Frontotemporal Dementia
Genomic Mutation Name (MET1):
Genomic Mutation Name (NT1):
dbSNP ID:
Coding/Non-Coding: Coding
Genomic Region: Exon 2
Mutation Type: Point, Missense
Codon Change: GGA to AGA

Findings

This mutation was identified in an individual diagnosed with the behavioral variant of frontotemporal dementia. The proband showed progressive deterioration of behavior and cognition and frontal and temporal atrophy by MRI. She had a family history of dementia, but DNA was not available from her father and two siblings (deceased), and therefore pathogenicity could not be determined. The G55R mutation was absent in 150 neurologically healthy subjects, aged more than 65 years, as well as in 152 patients with clinically diagnosed familial and sporadic FTD (Iyer et al., 2013).

Neuropathology

Unknown.

Biological Effect

This mutation, in the alternatively spliced exon 2 of MAPT, causes a substitution of arginine for glycine in a highly conserved, acidic region of the protein. In vitro studies showed that the 4-repeat (4R) isoform of tau with the G55R mutation nucleates microtubule assembly more effectively than wild-type 4R tau. This effect appears to be isoform-specific in that no difference in microtubule nucleation was seen when the mutation was introduced in 3R tau. The G55R mutation does not affect the dynamics of microtubule lengthening or shortening (Iyer et al., 2013).

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

References

Paper Citations

  1. . A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function. PLoS One. 2013;8(9):e76409. Epub 2013 Sep 27 PubMed.

Further Reading

Learn More

Primary Papers

  1. . A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function. PLoS One. 2013;8(9):e76409. Epub 2013 Sep 27 PubMed.